These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7202863)

  • 1. Effect of experimental diabetes on the susceptibility of myelin proteins to proteolysis.
    Spritz N; Singh H; Marinan B; Silberlicht I
    Diabetes; 1981 Apr; 30(4):292-5. PubMed ID: 7202863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of peripheral nerve myelin in experimental diabetes.
    Spritz N; Singh H; Marinan B
    J Clin Invest; 1975 May; 55(5):1049-56. PubMed ID: 123535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of diabetic rat peripheral nerve myelin by macrophages increases with the presence of advanced glycosylation endproducts.
    Vlassara H; Brownlee M; Cerami A
    J Exp Med; 1984 Jul; 160(1):197-207. PubMed ID: 6736870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restricted hypotonic swelling of peripheral nerve myelin in streptozocin-induced diabetic rats.
    Kirschner DA; Eichberg J
    J Neurosci Res; 1994 Jun; 38(2):142-8. PubMed ID: 8078099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P0 phosphorylation in nerves from normal and diabetic rats: role of protein kinase C and turnover of phosphate groups.
    Rowe-Rendleman CL; Eichberg J
    Neurochem Res; 1994 Aug; 19(8):1023-31. PubMed ID: 7528347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of diabetes on leucine and fucose incorporation into PNS myelin proteins.
    Baughman S; Felten SY; Lee W; Moore SA; O'Connor BL; Peterson RG
    Horm Metab Res; 1981 Jun; 13(6):331-5. PubMed ID: 7262834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The action of trypsin on central and peripheral nerve myelin.
    Eylar EH; Roomi MW
    Adv Exp Med Biol; 1978; 100():307-28. PubMed ID: 696476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of a product from the trypsin-digested glycoprotein of sciatic nerve myelin.
    Roomi MW; Eylar EH
    Biochim Biophys Acta; 1978 Sep; 536(1):122-33. PubMed ID: 708755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protective effect of the active components of ERPC on diabetic peripheral neuropathy in rats.
    Hao GM; Liu YG; Wu Y; Xing W; Guo SZ; Wang Y; Wang ZL; Li C; Lv TT; Wang HL; Shi TJ; Wang W; Han J
    J Ethnopharmacol; 2017 Apr; 202():162-171. PubMed ID: 28315720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholipid metabolism and protein phosphorylation in sciatic nerve from genetically diabetic (db/db) mouse.
    Berti-Mattera LN; Eichberg J
    Diabetes; 1988 Dec; 37(12):1703-7. PubMed ID: 2461325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluidity of the myelin sheath in the peripheral nerves of diabetic rats.
    Zuvic-Butorac M; Kriz J; Simonic A; Schara M
    Biochim Biophys Acta; 2001 Sep; 1537(2):110-6. PubMed ID: 11566254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of the polypeptides of mammalian peripheral nerve myelin.
    Singh H; Silberlicht I; Singh IJ
    Brain Res; 1978 Apr; 144(2):303-11. PubMed ID: 416884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of phosphoinositide metabolism, protein phosphorylation, and carbohydrate levels in sciatic nerve from Wistar fatty diabetic rats.
    Berti-Mattera LN; Lowery J; Day SF; Peterson RG; Eichberg J
    Diabetes; 1989 Mar; 38(3):373-8. PubMed ID: 2537246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased susceptibility to degradation by trypsin and subtilisin of in vitro peroxidized myelin proteins.
    Bongarzone ER; Soto EF; Pasquini JM
    Neurochem Res; 1995 Apr; 20(4):421-6. PubMed ID: 7651579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A biochemical comparison of Xenopus laevis and mammalian myelin from the central and peripheral nervous systems.
    Quarles RH; Sakuragawa N; Everly JL; Pasnak CF; Webster HD; Trapp BD
    J Neurobiol; 1978 May; 9(3):217-28. PubMed ID: 211203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction of altered metabolic activities in sciatic nerves of streptozocin-induced diabetic rats. Effect of ganglioside treatment.
    Bianchi R; Berti-Mattera LN; Fiori MG; Eichberg J
    Diabetes; 1990 Jul; 39(7):782-8. PubMed ID: 2162301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guanosine-5'-(3-O-thio)triphosphate-mediated stimulation of phosphoinositidase C in solubilized rat peripheral nerve myelin and its alteration in streptozotocin-induced diabetes.
    Mathew J; Eichberg J
    J Neurosci Res; 1994 Jan; 37(1):83-91. PubMed ID: 8145305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excessive nonenzymatic glycosylation of peripheral and central nervous system myelin components in diabetic rats.
    Vlassara H; Brownlee M; Cerami A
    Diabetes; 1983 Jul; 32(7):670-4. PubMed ID: 6862112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered protein phosphorylation in sciatic nerve from rats with streptozocin-induced diabetes.
    Schrama LH; Berti-Mattera LN; Eichberg J
    Diabetes; 1987 Nov; 36(11):1254-60. PubMed ID: 3666317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of tunicamycin on glycosylation of glycoproteins in peripheral nerve myelin.
    Uyemura K; Horie K; Kitamura K; Suzuki M; Sakamoto Y
    Prog Clin Biol Res; 1984; 146():481-6. PubMed ID: 6201916
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.